OTC Healthcare in Italy
Euromonitor International's OTC Healthcare in Italy market report offers a comprehensive guide to the size and shape of the market at a national level. It provides the latest retail sales data, allowing you to identify the sectors driving growth. It identifies the leading companies, the leading brands and offers strategic analysis of key factors influencing the market - be they new product developments, packaging innovations, economic/lifestyle influences, distribution or pricing issues. Forecasts illustrate how the market is set to change.
Get immediate access to strategic market analysis when you buy reports online
Tables: 108 | Publication date: Dec 2007
Why buy this report
- Get insight into trends in market performance
- Pinpoint growth sectors and identify factors driving change
- Identify market and brand leaders and understand the competitive environment
Product coverage
Adult mouthcare; Allergy care; Analgesics; Calming and sleeping products; Child-specific OTC healthcare; Cough; cold and allergy (hay fever) remedies; Digestive remedies; Ear care; Emergency contraception; Eye care; Medicated skin care; NRT Smoking cessation aids; OTC obesity; OTC statins; OTC triptans; Vitamins and dietary supplements; Wound treatments
Executive summary
Modest growth in 2006
Sales of OTC healthcare delivered a rather modest performance in 2006, growing by less than 2% in current value terms. Declines in sectors such as cough, cold and allergy remedies, digestive remedies and NRT smoking cessation aids undermined market growth. By contrast, vitamins and dietary supplements continued to perform well, contributing to driving up value sales of the entire industry. The sector benefited from increasing demand for supplementary nutrition products. Positive results were also recorded by wound treatments and eye care, which gained from manufacturers’ innovation activities. The child-specific OTC healthcare sector also delivered a positive performance.
Self-medication ever more important
In 2006, one of the key trends in Italy was an increase in self-medication within several sectors, like cough, cold and allergy remedies and vitamins and dietary supplements. There are a number of reasons for this trend. A key role is played by the ageing of Italian population, which is increasing pressure on the national health system, leading the government to promote self-medication for some age-related problems. A further important role is played by the increasing intensity of urban life, which is leading to a growing focus on health, favouring self-medication, as this enables people to save time by not seeing a doctor. The greater quantity of information that is available through the Internet and mass media represents an additional reason for this development.
Best performer Whitehall Italia gains second position in 2006
The Italian OTC market continued to be led by Bayer in 2006, with a 10% value share, despite a slight decline over the previous year. Bayer is particularly strong within analgesics, where it operates with its well-known Aspirina brand, and within vitamins and dietary supplements, with its Supradyn brand. Supported by the popularity of well-known brands such as Polase and Centrum, Whitehall Italia increased its value share in 2006, recording the best performance and taking second place in the rankings, at the expense of ACRAF-Gruppo Angelini. Angelini remains strong in analgesics, where it leads with its Tachipirina brand.
Supermarkets to challenge pharmacy monopoly
The chemists/pharmacies channel maintained its near monopoly across all OTC healthcare sectors in Italy in 2006, despite the government allowing the sale of OTC remedies in non-pharmacy outlets, like supermarkets and hypermarkets. The progressive deregulation of the pharmacy market will reshape the structure of the supply chain in the near future. Supermarkets, hypermarkets and convenience stores will increasingly gain share within OTC healthcare, increasing competition within the non-prescription medicines market in Italy and contributing to a decline in unit prices.
Modest growth expected despite wider availability
The Italian OTC healthcare market is likely to see modest growth during the forecast period. Overall, the market will face numerous variables, such as the introduction of new generic drugs and a further reduction in the retail prices of OTC remedies, due to increasing competition. Consumer demand for vitamins and dietary supplements will continue to drive overall sales of OTC products, with wound treatments, eye care and NRT smoking cessation also contributing to growth. The deregulation of distribution in 2006 will increase competition, as well as widening the availability of pharmaceuticals. At the same time, the Italian government is likely to cap future healthcare spending as the ageing population will put ever more strain on national healthcare service resources. To this end, the government will increasingly encourage pharmaceutical companies to make more drugs available over-the-counter, and educate the public to enable them to make more healthcare decisions themselves.
Table of contents
OTC HEALTHCARE IN ITALY : MARKET INSIGHT
EXECUTIVE SUMMARY
Modest growth in 2006
Self-medication ever more important
Best performer Whitehall Italia gains second position in 2006
Supermarkets to challenge pharmacy monopoly
Modest growth expected despite wider availability
KEY TRENDS AND DEVELOPMENTS
OTC Products on Supermarkets’ Shelves
Greying Population
Wellness Trend Affects OTC Medicines
The Importance of Health in Modern Lifestyles
Targeting Specific Segments
MARKET INDICATORS
Table 1 Life Expectancy at Birth 2001-2006
MARKET DATA
Table 2 Sales of OTC Healthcare by Sector: Value 2001-2006
Table 3 Sales of OTC Healthcare by Sector: % Value Growth 2001-2006
Table 4 OTC Healthcare Company Shares by Retail Value 2002-2006
Table 5 OTC Healthcare Brand Shares by Retail Value 2003-2006
Table 6 Penetration of Private Label by Sector 2002-2006
Table 7 Sales of OTC Healthcare by Distribution Format: % Analysis 2001/2006
Table 8 Sales of OTC Healthcare by Sector and Distribution Format: % Analysis 2006
Table 9 Forecast Sales of OTC Healthcare by Sector: Value 2006-2011
Table 10 Forecast Sales of OTC Healthcare by Sector: % Value Growth 2006-2011
APPENDIX
OTC Registration and Classification
Table 11 Number of Prescriptions Issued 2003-2006
De-listing Or De-reimbursement
Advertising
Packaging and waste
Labelling
Distribution
Vitamins and Dietary Supplements Registration and Classification
Generics
Consumer Expenditure on Health Goods and Medical Services
Table 12 Consumer Expenditure on Health Goods and Medical Services 2001-2006
DEFINITIONS
Sources
Summary 1 Research Sources
LOCAL COMPANY PROFILES - ITALY
A MENARINI INDUSTRIE FARMACEUTICHE RIUNITE SRL - OTC HEALTHCARE - ITALY
STRATEGIC DIRECTION
KEY FACTS
Summary 2 A Menarini Industrie Farmaceutiche Riunite Srl: Key Facts
Summary 3 A Menarini Industrie Farmaceutiche Riunite Srl: Operational Indicators
COMPANY BACKGROUND
PRODUCTION
COMPETITIVE POSITIONING
Summary 4 A Menarini Industrie Farmaceutiche Riunite Srl: Competitive Position 2006
AZIENDE CHIMICHE RIUNITE ANGELINI FRANCESCO ACRAF SPA - OTC HEALTHCARE - ITALY
STRATEGIC DIRECTION
KEY FACTS
Summary 5 Aziende Chimiche Riunite Angelini Francesco ACRAF SpA: Key Facts
Summary 6 Aziende Chimiche Riunite Angelini Francesco ACRAF SpA: Operational Indicators
COMPANY BACKGROUND
PRODUCTION
Summary 7 Aziende Chimiche Riunite Angelini Francesco ACRAF SpA: Production Statistics 2006
COMPETITIVE POSITIONING
Summary 8 Aziende Chimiche Riunite Angelini Francesco ACRAF SpA: Competitive Position 2006
BRACCO SPA - OTC HEALTHCARE - ITALY
STRATEGIC DIRECTION
KEY FACTS
Summary 9 Bracco SpA: Key Facts
Summary 10 Bracco SpA: Operational Indicators
COMPANY BACKGROUND
PRODUCTION
COMPETITIVE POSITIONING
Summary 11 Bracco SpA: Competitive Position 2006
CHIESI FARMACEUTICI SPA - OTC HEALTHCARE - ITALY
STRATEGIC DIRECTION
KEY FACTS
Summary 12 Chiesi Farmaceutici SpA: Key Facts
Summary 13 Chiesi Farmaceutici SpA: Operational Indicators
COMPANY BACKGROUND
PRODUCTION
COMPETITIVE POSITIONING
Summary 14 Chiesi Farmaceutici SpA: Competitive Position 2006
PERFETTI VAN MELLE SPA - OTC HEALTHCARE - ITALY
STRATEGIC DIRECTION
KEY FACTS
Summary 15 Perfetti Van Melle SpA: Key Facts
Summary 16 Perfetti Van Melle SpA: Operational Indicators
COMPANY BACKGROUND
PRODUCTION
COMPETITIVE POSITIONING
Summary 17 Perfetti Van Melle SpA: Competitive Position 2006
RECORDATI INDUSTRIA CHIMICA E FARMACEUTICA SPA - OTC HEALTHCARE - ITALY
STRATEGIC DIRECTION
KEY FACTS
Summary 18 Recordati Industria Chimica e Farmaceutica SpA: Key Facts
Summary 19 Recordati Industria Chimica e Farmaceutica SpA: Operational Indicators
COMPANY BACKGROUND
PRODUCTION
Summary 20 Recordati Industria Chimica e Farmaceutica SpA: Production Statistics 2006
COMPETITIVE POSITIONING
Summary 21 Recordati Industria Chimica e Farmaceutica SpA: Competitive Position 2006
SANOFI-AVENTIS SPA - OTC HEALTHCARE - ITALY
STRATEGIC DIRECTION
KEY FACTS
Summary 22 Sanofi-Aventis SpA: Key Facts
Summary 23 Sanofi-Aventis SpA: Operational Indicators
COMPANY BACKGROUND
PRODUCTION
COMPETITIVE POSITIONING
Summary 24 Sanofi-Aventis SpA: Competitive Position 2006
SIGMA-TAU INDUSTRIE FARMACEUTICHE RIUNITE SPA - OTC HEALTHCARE - ITALY
STRATEGIC DIRECTION
KEY FACTS
Summary 25 Sigma-Tau Industrie Farmaceutiche Riunite SpA: Key Facts
Summary 26 Sigma-Tau Industrie Farmaceutiche Riunite SpA: Operational Indicators
COMPANY BACKGROUND
PRODUCTION
COMPETITIVE POSITIONING
Summary 27 Sigma-Tau Industrie Farmaceutiche Riunite SpA: Competitive Position 2006
ZAMBON ITALIA SPA - OTC HEALTHCARE - ITALY
STRATEGIC DIRECTION
KEY FACTS
Summary 28 Zambon Italia SpA: Key Facts
Summary 29 Zambon Italia SpA: Operational Indicators
COMPANY BACKGROUND
PRODUCTION
Summary 30 Zambon Italia SpA: Production Statistics 2006
COMPETITIVE POSITIONING
Summary 31 Zambon Italia SpA: Competitive Position 2006
ANALGESICS IN ITALY
HEADLINES
TRENDS
COMPETITIVE LANDSCAPE
PROSPECTS
SECTOR DATA
Table 13 Sales of Analgesics by Subsector: Value 2001-2006
Table 14 Sales of Analgesics by Subsector: % Value Growth 2001-2006
Table 15 Herbal vs Standard Topical Analgesics 2001/2006
Table 16 Analgesics Company Shares by Retail Value 2002-2006
Table 17 Analgesics Brand Shares by Retail Value 2003-2006
Table 18 Forecast Sales of Analgesics by Subsector: Value 2006-2011
Table 19 Forecast Sales of Analgesics by Subsector: % Value Growth 2006-2011
COUGH, COLD AND ALLERGY (HAY FEVER) REMEDIES IN ITALY
HEADLINES
TRENDS
COMPETITIVE LANDSCAPE
PROSPECTS
SECTOR DATA
Table 20 Sales of Cough, Cold and Allergy (Hay Fever) Remedies by Subsector: Value 2001-2006
Table 21 Sales of Cough, Cold and Allergy (Hay Fever) Remedies by Subsector: % Value Growth 2001-2006
Table 22 Sales of Decongestants by Type: Value 2001-2006
Table 23 Sales of Decongestants by Type: % Value Growth 2001-2006
Table 24 Sales of Child-specific Cough, Cold and Allergy (Hay Fever) Remedies by Type: Value 2001-2006
Table 25 Sales of Child-specific Cough, Cold and Allergy (Hay Fever) Remedies by Type: % Value Growth 2001-2006
Table 26 Herbal vs Standard Cough, Cold and Allergy (Hay Fever) Remedies 2001/2006
Table 27 Cough, Cold and Allergy (Hay Fever) Remedies Company Shares by Retail Value 2002-2006
Table 28 Cough, Cold and Allergy (Hay Fever) Remedies Brand Shares by Retail Value 2003-2006
Table 29 Forecast Sales of Cough, Cold and Allergy (Hay Fever) Remedies by Subsector: Value 2006-2011
Table 30 Forecast Sales of Cough, Cold and Allergy (Hay Fever) Remedies by Subsector: % Value Growth 2006-2011
DIGESTIVE REMEDIES IN ITALY
HEADLINES
TRENDS
COMPETITIVE LANDSCAPE
PROSPECTS
SECTOR DATA
Table 31 Sales of Digestive Remedies by Subsector: Value 2001-2006
Table 32 Sales of Digestive Remedies by Subsector: % Value Growth 2001-2006
Table 33 Herbal vs Standard Digestive Remedies 2001/2006
Table 34 Digestive Remedies Company Shares by Retail Value 2002-2006
Table 35 Digestive Remedies Brand Shares by Retail Value 2003-2006
Table 36 Forecast Sales of Digestive Remedies by Subsector: Value 2006-2011
Table 37 Forecast Sales of Digestive Remedies by Subsector: % Value Growth 2006-2011
MEDICATED SKIN CARE IN ITALY
HEADLINES
TRENDS
COMPETITIVE LANDSCAPE
PROSPECTS
SECTOR DATA
Table 38 Sales of Medicated Skin Care by Subsector: Value 2001-2006
Table 39 Sales of Medicated Skin Care by Subsector: % Value Growth 2001-2006
Table 40 Herbal vs Standard Medicated Skin Care 2001/2006
Table 41 Medicated Skin Care Company Shares by Retail Value 2002-2006
Table 42 Medicated Skin Care Brand Shares by Retail Value 2003-2006
Table 43 Acne Treatments Brand Shares by Retail Value 2003-2006
Table 44 Hair Loss Treatments Brand Shares by Retail Value 2003-2006
Table 45 Forecast Sales of Medicated Skin Care by Subsector: Value 2006-2011
Table 46 Forecast Sales of Medicated Skin Care by Subsector: % Value Growth 2006-2011
VITAMINS AND DIETARY SUPPLEMENTS IN ITALY
HEADLINES
TRENDS
COMPETITIVE LANDSCAPE
PROSPECTS
SECTOR DATA
Table 47 Sales of Vitamins and Dietary Supplements by Subsector: Value 2001-2006
Table 48 Sales of Vitamins and Dietary Supplements by Subsector: % Value Growth 2001-2006
Table 49 Sales of Vitamins by Type: Value 2001-2006
Table 50 Sales of Vitamins by Type: % Value Growth 2001-2006
Table 51 Vitamins and Dietary Supplements Company Shares by Retail Value 2002-2006
Table 52 Vitamins and Dietary Supplements Brand Shares by Retail Value 2003-2006
Table 53 Vitamins Brand Shares by Retail Value 2003-2006
Table 54 Sales of Dietary Supplements by Type: Value 2001-2006
Table 55 Sales of Dietary Supplements by Type: % Value Growth 2001-2006
Table 56 Dietary Supplements Brand Shares by Retail Value 2003-2006
Table 57 Forecast Sales of Vitamins and Dietary Supplements by Subsector: Value 2006-2011
Table 58 Forecast Sales of Vitamins and Dietary Supplements by Subsector: % Value Growth 2006-2011
NRT SMOKING CESSATION AIDS IN ITALY
HEADLINES
TRENDS
COMPETITIVE LANDSCAPE
PROSPECTS
SECTOR INDICATORS
Table 59 Number of Smokers by Gender 2001-2006
SECTOR DATA
Table 60 Sales of Smoking Cessation Aids by Subsector: Value 2001-2006
Table 61 Sales of Smoking Cessation Aids by Subsector: % Value Growth 2001-2006
Table 62 Smoking Cessation Aids Company Shares by Retail Value 2002-2006
Table 63 Smoking Cessation Aids Brand Shares by Retail Value 2003-2006
Table 64 Forecast Sales of Smoking Cessation Aids by Subsector: Value 2006-2011
Table 65 Forecast Sales of Smoking Cessation Aids by Subsector: % Value Growth 2006-2011
EYE CARE IN ITALY
TRENDS
SECTOR DATA
Table 66 Sales of Eye Care by Subsector: Value 2001-2006
Table 67 Sales of Eye Care by Subsector: % Value Growth 2001-2006
Table 68 Eye Care Company Shares by Retail Value 2002-2006
Table 69 Eye Care Brand Shares by Retail Value 2003-2006
Table 70 Forecast Sales of Eye Care by Subsector: Value 2006-2011
Table 71 Forecast Sales of Eye Care by Subsector: % Value Growth 2006-2011
EAR CARE IN ITALY
TRENDS
ADULT MOUTHCARE IN ITALY
TRENDS
CALMING AND SLEEPING PRODUCTS IN ITALY
TRENDS
WOUND TREATMENTS IN ITALY
TRENDS
SECTOR DATA
Table 72 Sales of Wound Treatments by Subsector: Value 2001-2006
Table 73 Sales of Wound Treatments by Subsector: % Value Growth 2001-2006
Table 74 Wound Treatments Company Shares by Retail Value 2002-2006
Table 75 Wound Treatments Brand Shares by Retail Value 2003-2006
Table 76 Forecast Sales of Wound Treatments by Subsector: Value 2006-2011
Table 77 Forecast Sales of Wound Treatments by Subsector: % Value Growth 2006-2011